The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
AI/ML-derived mechanistically interpretable whole-genome biomarkers of patient survival in pre-treatment primary neuroblastoma tumors and whole blood.
 
Orly Alter
Employment - Prism AI Therapeutics, Inc.; https://prism-ai.com
Leadership - Prism AI Therapeutics, Inc.; https://prism-ai.com
Stock and Other Ownership Interests - Prism AI Therapeutics, Inc.; https://prism-ai.com
Patents, Royalties, Other Intellectual Property - 1. O. Alter, “Genetic Alterations in Glioblastoma,” European Patent EP 2773777 A4 (May 2020); https://patents.google.com/patent/EP2773777A4; 2. O. Alter, “Genetic Alterations in Glioma,” United States Patent US 10202643 B2 (February 2019); https://patents.google.com/patent/US10202643B2
 
Elizabeth Newman
No Relationships to Disclose
 
Sri Priya Ponnapalli
No Relationships to Disclose
 
Jessica W. Tsai
No Relationships to Disclose